Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

MFI2-AS1 enhances the survival of esophageal cancer cell via regulation of miR-331-3p/SOX4

Feng Lin¹, Angui Li¹, Jianfei Song¹, Kai Hu², Haiyong Wang¹

¹Department of Thoracic Surgery; ²Department of Central Sterile Supply, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541001, China.

For correspondence:-

Accepted: 28 October 2020 Published: 30 November 2020

Citation: Lin F, Li A, Song J, Hu K, Wang H. MFI2-AS1 enhances the survival of esophageal cancer cell via regulation of miR-331-3p/SOX4. Trop J Pharm Res 2020; 19(11):2287-2293 doi: 10.4314/tjpr.v19i11.6

© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the specific role of melanotransferrin antisense RNA (MFI2-AS1) in esophageal cancer (EC) progression.

Methods: The differential expression of MFI2-AS1 in EC tissues and cells was determined using quantitative reverse transcription–polymerase chain reaction (qRT-PCR). Silencing MFI2-AS1 was performed by transfection with specific short hairpin RNAs targeting MFI2-AS1. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT) and flow cytometry (FC) were used to assess cell viability and apoptosis of EC cells, respectively. The sponging microRNA (miRNA) of MFI2-AS1 was validated using luciferase activity and RNA immunoprecipitation assays while the downstream target gene of the sponging miRNA was evaluated by luciferase activity assay.

Results: MFI2-AS1 was significantly enhanced in EC tissues (p < 0.01) and indicated a poor prognosis in EC patients. Knockdown of MFI2-AS1 in EC cells decreased cell viability and promoted cell apoptosis of EC cells. Functionally, MFI2-AS1 targeted miR-331-3p, and sex-determining region on Y-chromosome-related high-mobility-group box4 (SOX4) was identified as a target gene of miR-331-3p. Ectopic expression of SOX4 counteracted the suppressive effect of MFI2-AS1 knockdown on EC cell viability and stimulative effect on EC cell apoptosis.

Conclusion: The pro-oncogenic effect of MFI2-AS1 on EC progression occurs via the regulation of the miR-331-3p/SOX4 axis, providing a new potential therapeutic target for EC.

Keywords: MFI2-AS1, MiR-331-3p, SOX4, Esophageal cancer, Caner progression, Pro-oncogenic